In Vitro Activity of Novel Oxazolidinone Analogs and 13 Conventional Antimicrobial Agents against Clinical Isolates of Staphylococcus aureus in Beijing, China

In vitro and intracellular activity of 4-substituted piperazinyl phenyl oxazolidinone analogues against Mycobacterium tuberculosis

(2014) D. Wang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tedizolid (TR-701): a new oxazolidinone with enhanced potency

(2012) Zeina A. Kanafani et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Antibacterial activity of LCB01-0062, a novel oxazolidinone

(2012) Sung-Ji Jung et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Five decades of MRSA: controversy and uncertainty continues

(2011) Barry Cookson   LANCET

Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan

(2010) Yurika Ikeda-Dantsuji et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Improved Antimicrobial Activity of Linezolid against Vancomycin-Intermediate Staphylococcus aureus

(2008) Y. Watanabe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China

(2008) Hui Wang et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Linezolid for the treatment of infections caused by Gram-positive pathogens in China

(2008) Dong-fang Lin et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS